In agreement with previous work49, our results suggest that, beyond MYC downregulation, OTX-015, and perhaps other BETis, could elicit their antitumour capabilities also by disrupting the metabolic equilibrium between antioxidants and ROS, thereby eventually leading to cancer cell death. The gene discussed is MYC; the disease is cancer.